Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.18B | -3.73%10.73B | 0.10%44.8B | -2.88%11.34B | 2.61%11.15B | 2.57%44.76B | -6.18%11.21B | -5.11%11.01B | 11.84%11.68B | 12.59%10.86B |
| Cost of revenue | 8.9B | -6.82%8.58B | 0.47%36.35B | -1.05%9.34B | 5.97%9.21B | 1.81%36.19B | -3.72%9.16B | -6.65%8.9B | 10.73%9.44B | 8.98%8.69B |
| Gross profit | 2.28B | 10.96%2.15B | -1.43%8.45B | -10.58%2B | -10.82%1.94B | 5.91%8.57B | -15.77%2.05B | 2.00%2.1B | 16.74%2.24B | 29.78%2.18B |
| Operating expense | 1.66B | 3.53%1.59B | 2.55%6.26B | 2.74%1.55B | 7.03%1.54B | 9.61%6.1B | 12.40%1.62B | 9.75%1.53B | 7.60%1.51B | 8.54%1.44B |
| Operating profit | 624.7M | 39.42%560.57M | -11.25%2.19B | -37.93%455.62M | -45.57%402.08M | -2.24%2.47B | -56.83%427.51M | -14.25%571.71M | 41.41%734.06M | 109.58%738.66M |
| Net non-operating interest income (expenses) | 995K | 128.82%2.87M | 58.38%-22.05M | 36.42%-7.76M | 19.95%-9.95M | -83.84%-52.97M | -91.33%-12.5M | -42.15%-15.85M | -133.72%-12.2M | -110.13%-12.43M |
| Non-operating interest income | --12.58M | -6.72%14.33M | 64.94%71.61M | 70.62%17.52M | 77.17%15.36M | 21.47%43.42M | 13.18%14.54M | 29.72%9.93M | 27.94%10.27M | 20.28%8.67M |
| Non-operating interest expense | --11.58M | -54.71%11.47M | -2.83%93.66M | 12.51%25.28M | 19.97%25.31M | 49.31%96.39M | 39.52%27.04M | 37.09%25.78M | 69.62%22.47M | 60.77%21.1M |
| Net investment income | 18.8M | -204.45%-129.68M | 142.21%101.18M | 61.69%157.8M | 1,346.40%124.15M | -84.22%41.78M | -231.20%-78.61M | -64.08%32.75M | 26.61%97.6M | -127.20%-9.96M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 99.67%65.5M | 32.8M | 0 | |||||||
| Income from associates and other participating interests | 3.94M | 632.09%12.37M | 299.69%10.46M | -86.70%3.14M | -72.21%1.69M | -95.22%2.62M | -144.28%-21.91M | -142.02%-5.12M | 1,439.32%23.57M | 218.90%6.08M |
| Special income (charges) | 2.6M | 110.34%143K | 3,406.56%1.61B | 486,439.05%1.64B | -853.79%-1.38M | 84.98%-48.64M | 10.16%-46.67M | 99.36%-1.49M | 99.16%-338K | -19.83%-145K |
| Less:Other special charges | ---2.6M | -110.34%-143K | -9,726.40%-1.65B | -486,439.05%-1.64B | 853.79%1.38M | -93.85%17.12M | 140.95%15.14M | -99.36%1.49M | -99.16%338K | 19.83%145K |
| Less:Write off | ---- | ---- | 24.48%39.24M | ---- | ---- | -30.95%31.53M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 25.45M | 118.61%11.11M | -37.74%51.44M | -35.90%12.01M | -81.25%5.08M | -20.25%82.63M | 50.47%24.73M | -60.13%12.05M | 32.94%18.73M | -36.73%27.11M |
| Income before tax | 676.49M | -12.32%457.38M | 58.44%4.01B | 162.89%2.26B | -30.38%521.67M | -2.65%2.53B | -72.34%292.56M | 12.43%626.85M | 52.99%861.43M | 78.08%749.31M |
| Income tax | 151.42M | -37.80%140.43M | 117.22%1.36B | 184.47%720.75M | 3.04%225.79M | 64.11%626.56M | -89.10%9.19M | 24.45%144.89M | 226.06%253.37M | 112.01%219.12M |
| Net income | 525.07M | 7.12%316.95M | 39.10%2.65B | 153.90%1.54B | -44.19%295.88M | -14.15%1.9B | -70.89%283.37M | 9.26%481.96M | 25.29%608.06M | 67.04%530.19M |
| Net income continuous operations | --525.07M | 7.12%316.95M | 39.10%2.65B | 153.90%1.54B | -44.19%295.89M | -14.15%1.9B | -70.89%283.36M | 9.26%481.96M | 25.29%608.06M | 67.04%530.19M |
| Noncontrolling interests | 11.13M | 103.20%1.62M | -67.93%-135.84M | -322.04%-31.44M | -1,222.46%-50.47M | -197.00%-80.89M | -467.70%-67.32M | -260.84%-32.22M | -42.80%14.16M | -77.85%4.5M |
| Net income attributable to the company | 513.93M | -8.96%315.33M | 40.27%2.78B | 165.25%1.58B | -34.12%346.35M | -7.00%1.98B | -63.28%350.69M | 22.11%514.18M | 28.94%593.9M | 76.94%525.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 513.93M | -8.96%315.33M | 40.27%2.78B | 165.25%1.58B | -34.12%346.35M | -7.00%1.98B | -63.28%350.69M | 22.11%514.18M | 28.94%593.9M | 76.94%525.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 42.17 | -8.94%25.88 | 40.27%228.42 | 165.28%129.27 | -34.12%28.42 | -7.00%162.84 | -63.28%28.78 | 22.11%42.19 | 28.95%48.73 | 76.95%43.14 |
| Diluted earnings per share | 42.17 | -8.94%25.88 | 40.27%228.42 | 165.27%129.2661 | -34.12%28.42 | -7.00%162.84 | -63.28%28.7762 | 22.11%42.19 | 28.95%48.73 | 76.95%43.14 |
| Dividend per share | 0 | 0 | 19.51%49 | 42.86%20 | 0 | 70.83%41 | 68.75%27 | 0 | 75.00%14 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |